MC
TMDX icon

Moors & Cabot’s Transmedics TMDX Stock Holding History

Moors & Cabot’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$206K Buy
2,077
+211
+11% +$27.5K 0.01% 850
2025
Q4 		$227K Hold
1,866
– – 0.01% 810
2025
Q3 		$209K Buy
+1,866
New +$218K 0.01% 825

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Moors & Cabot's TMDX Position: Q1 2026 in Review

Moors & Cabot increased its Transmedics (TMDX) stake by 11% in Q1 2026, buying an estimated $27.5K and bringing the position to 2,077 shares worth $206K. The position accounts for 0.01% of the portfolio, ranked #850.

Moors & Cabot first reported a position in TMDX in Q3 2025 and has held it in 3 quarters since. The position peaked at $227K in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Moors & Cabot held 2,077 shares of Transmedics worth $206K as of Q1 2026.
  • Moors & Cabot bought 211 Transmedics shares in Q1 2026, an estimated $27.5K.
  • Transmedics made up 0.01% of Moors & Cabot's portfolio in Q1 2026, its #850 holding.
  • Moors & Cabot first reported a position in Transmedics in Q3 2025 and has held it in 3 quarters since.
  • Moors & Cabot's Transmedics position peaked at $227K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.